跳到主要內容

臺灣博碩士論文加值系統

(216.73.217.174) 您好!臺灣時間:2026/08/09 13:14
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:陳琮漢
研究生(外文):Tsung-han Chen
論文名稱:乳酸菌抑制幽門桿菌及其尿素酶活性之探討
論文名稱(外文):Inhibition of Helicobacter pylori and associated urease by lactic acid bacteria
指導教授:張竣凱張竣凱引用關係王淑珍
指導教授(外文):Jiunn-kae ChangShu-jen Wang
學位類別:碩士
校院名稱:嘉南藥理科技大學
系所名稱:生物科技系暨研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2011
畢業學年度:99
語文別:中文
論文頁數:100
中文關鍵詞:幽門螺旋桿菌乳酸菌細菌素尿素酶活性
外文關鍵詞:Lactic acid bacteria (LAB)Helicobacter pyloribacteriocinurease activity
相關次數:
  • 被引用被引用:2
  • 點閱點閱:1119
  • 評分評分:
  • 下載下載:158
  • 收藏至我的研究室書目清單書目收藏:1
幽門桿菌感染是全世界常見的疾病之一,平均感染率高達50% 以上,許多胃部疾病與幽門桿菌有關係,如胃癌中的胃腺癌、胃黏膜淋巴組織的淋巴瘤皆與幽門桿菌感染有關。最近,益生菌乳酸菌對人體有益的功能,如對腸道有害菌的抑制,抗癌及免疫的效果,降低膽固醇及改善營養等,與抑制幽門桿菌的機制在近年來也不斷被證實。因此,本篇將針對乳酸菌抑制幽門桿菌的機制及其能力進行探討。
本研究以洋菜擴散法與生長抑制試驗進行分析,將分離之乳酸菌株發酵產物對2株幽門桿菌BCRC 17023、BCRC 15415進行生長抑制作用,共篩選出15株乳酸菌對幽門桿菌具有抑制作用,且抑制之效果優於 L. lactis subsp. lactis BCRC10791乳酸菌株。在體外試驗中,12.5% 乳酸菌發酵液為抑制幽門桿菌之最低抑制濃度,且實驗結果顯示,有10株乳酸菌株抑制幽門桿菌效果明顯優於BCRC 10791與 B. lactis BCRC 17394 (Bb-12)等乳酸菌株,其抑制幽門桿菌生長之效果可達到70% 以上;此外,由於幽門桿菌內部及表面都具有很高的尿素酶活性,故將10株乳酸菌發酵液進行抑制幽門桿菌尿素酶活性探討,結果顯示,B0001、B0003、B0055、B0077、B0155等乳酸菌株對幽門桿菌BCRC 17023具有較佳抑制能力;B0055、B0056等乳酸菌株對幽門桿菌BCRC 15415具有較佳的抑制能力。由上述篩選出的乳酸菌株進行16S rDNA序列分析,結果顯示,乳酸菌B0001、B0003、B0055、B0077、B0155為 Lactobacillus plantarum,乳酸菌B0056為 Pediococcus pentosaceus。在細胞吸附試驗中發現乳酸菌發酵液能有效降低幽門桿菌吸附Caco-2與TSGH9201之菌落數。綜合上述研究結果顯示,本實驗篩選出的6株乳酸菌菌株所產生之細菌素均具有抑制幽門桿菌生長與其尿素酶活性的能力及降低幽門桿菌吸附細胞之能力。
Helicobacter pylori that infects over 50% of the population in world wide, has been linked to the development of gastric adeno-carcinoma and mucosa-associated lymphoid tissue lymphoma. Recently, lactic acid bacteria (LAB) has attracted much attention due to their potential inhibition of pathogen including H. pylori , Streptococcus mutans and Staphyloccus aureus. Therefore, the effects of lactic acid bacteria isolated from fermented vegetables on H.pylori were tested.
A standard antimicrobial plate well diffusion assay was employed to examine inhibitory effects on H. pylori BCRC17023 and BCRC15415. 15 strains of LAB demonstrated inhibition of Helicobacter pylori growth in comparison with L. lactis subsp. lactis BCRC10791. In vitro test, the concentration of spend culture supernatant (SCS) against BCRC17023 and BCRC15415 was served in 12.5%. Among of them, 10 strains of LAB showed a significant inhibition rate (70%) against H. pylori compared to BCRC10791 and B. lactis BCRC17394 (Bb-12). Further, the effect of LAB strains on the urease activity of H.pylori was examined. The urease activity of H. pylori BCRC17023 was significantly inhibited by the presence of B0001, B0003, B0055, B0077 and B0155-SCS. H. pylori BCRC15415 was significantly inhibited by B0055, B0056-SCS. Strains of B0001, B0003, B0055, B0077, B0155 were identified as Lactobacillus plantarum and B0056 was Pediococcus pentosaceus , based on 16S rDNA sequence. Treatment of H. pylori BCRC17023 and BCRC15415 with LAB-SCS significantly reduced the number of H. pylori adhering to the monolayer of Caco-2 and TSGH9201 cell lines.
中文摘要........................... Ⅰ
英文摘要.......................... .Ⅱ
本文目錄........................... Ⅳ
表目錄............................ Ⅸ
圖目錄............................ Ⅹ
縮寫表............................ XI
1.吳明賢、王錦堂、林肇堂。幽門螺旋桿菌與胃癌。內科學誌。1998;9:107-114。
2.Liang HF, Chen CN, Chang Y, et al. Natural antimicrobial agent (reuterin) produced by Lactobacillus reuteri for sanitization of biological tissues inoculated with Pseudomonas aeruginosa. Biotechnol Bioeng. 2003;84(2):233-239.
3.Choi HJ, Cheigh CI, Kim SB, et al. Weissella kimchii sp. nov., a novel lactic acid bacterium from kimchi. Int J Syst Evol Microbiol. 2002;52(2):507-511.
4.Parvez S, Malik KA, Kang SA, et al. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006 Jun;100(6):1171-1185.
5.杜旻倫。雙叉桿菌抑制幽門螺旋桿菌生長之研究。輔仁大學食品營養學系碩士論文。2004。
6.陳歆翎。發酵食品中耐鹽乳酸菌之篩選。朝陽科技大學應用化學系碩士論文。2007。
7.Orla-Jensen S. The Main Lines of the Natural Bacterial System. J Bacteriol. 1921 May; 6(3):263-73.
8.廖啟成。乳酸菌之分類應用。食品工業月刊。1998;28:11-22。
9.Stiles ME, Holzapfel WH. Lactic acid bacteria of foods and their current taxonomy. Int J Food Microbiol. 1997;36(1):1-29.
10.Loosdrecht MC, Lyklema J, Norde W, et al.. The role of bacterial cell wall hydrophobicity in adhesion. Appl Environ Microbiol. 1987;53(8):1893-7.
11.Schiffrin EJ, Brassart D, Servin AL, et al. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr. 1997 Aug;66(2):515S-520S.
12.Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother. 1982;10:263-270.
13.陳勁初。以乳酸菌保存食品機制。食品工業月刊。1991;23(9):17-21。
14.Helander D, Rapier A, Dreilinger M, et al. Duodenal bicarbonate secretion of Helicobacter pylori and duodenal structure and function in humans. Gastroenterol.1996;110:705-16.
15.Barefoot S, Nettles C. Antibiosis revisited : bacteriocins produced by dairy starter cultures. J Dairy Sci. 1993;76(8) : 2366-79.
16.黃惠宇。腸道系統守護神-乳酸菌。科學月刊。2006;37(2):104-107。
17.Jiagn T, Mustapha A, Savaiano DA. Improvement of lactose digestion in humans by injection of fermented milk containing Bifidobacterium longum. J. Dairy Sci. 1996;79:750-757.
18.Alm L. Effect of fermentation on L(+) and D(-) lactic acid in milk. J. Dairy Sci. 1982;65:515-520.
19.Hirayama K, Rafter J. The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations. Antonie van Leeuwenhoek. 1999;76: 391-394.
20.Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr. 2001;73(2):451-455.
21.邱雪惠。乳酸菌之抗癌機制。食品工業月刊。2004;36:27-33。
22.Blaise CH, Rex G, Annick M. Cross-Talk between Probiotic Bacteria and the Host Immune System. J Nutr. 2007;137: 781-790.
23.Arthur C. Antiallergic effects of probiotics. J Nutr. 2007;137: 794- 797.
24.Nonaka Y, Izumo T, Izumi F, et al. Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production. Int Arch Allergy Immunol. 2008;145(3):249-257.
25.Gaidenko TA, Ya KM. Cloning of Bacillus licheniformis genes which control the biosynthesis of bacteriocin. Mol Gene Microbiol. 1988;1: 24-28.
26.Yudina TG, Egorovns N, Loriya ZHK, et al. Biological activity of Bacillus thuringiensis parasporal crystal. Izv Akad Nauk USSR Ser Biol. 1988;0:427-436.
27.Tagg JR, Dajanii AS, Wannamaker LW. Bacteriocins of Gram-positive bacteria. Bacteriol Rev. 1976;40:722-756.
28.程孝維。產細菌素乳酸菌的分離、篩選及細菌素純化條件之研究。嘉南藥理科技大學生物科技系碩士論文。2005。
29.Kelstrup J, Gibbons RJ. Bacteriocins from human and rodent streptococci. Arch Oral Biol. 1969;14:251-258.
30.陳俊嘉。由乳酸菌發酵液中分離細菌素及其特性之探討。嘉南藥理科技大學生物科技系碩士論文。2006。
31.Nettles CG, Barefoot SF. Biochemical and genetic characteristics og bacteriocins of food associated lactic acid bacteria. J Food Prot. 1993;56:3338-356.
32.Tramer J, Fowler GG. Estimation of nisin in food. J Sci Food Agric. 1964;15:522-528.
33.Barefoot SF, Klaenhammer TR. Detection and activity of Lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol. 1983;45:1808-1815.
34.Abee T, Klaenhammer TR, Letellier L, Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that froms poration complexes in the cytoplasmic membrane. Appl Environ Microbiol. 1994;60(3):1006-1013.
35.Twomey D, Ross RP, Ryan M, et al. Lantibiotics produced by lactic acid bacteria: Structure, function and applications. Antonie van Leeuwenhoek. 2002;82(1-4):165-185.
36.Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: Safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001;71:1-20.
37.Hansen JN, Banerjee S, Buchman GW. Potential of small ribosomally synthesized bacteriocins in design of new food preservatives. J Food Saf. 1989;10:119-130.
38.Bhunia AK, Johnson MC, Ray B. Purification, characterization and antimicrobial spectrum of a bacteriocin produced by Pediococcus acidilactici. J Appl Bacteriol. 1988;65:261-268.
39.Davis DB, Dulbecco R, Eisen NH, et al. Microbiology 4th ed. 1990 :485-505.
40.Abee T, Krockel L, Hill C. Bacteriocins: modes of action and potentials in food prevervation and control of food poisoning. Int J Food Microbiol.1995; 28:169-185.
41.Orberg PK, Sandine WE. Microscale method for rapid isolaction of covalently closed circular plasmid DNA form group N streptococci. Appl Environ Microbiol. 1984;47:677-680.
42.Nissen MJ, Holo H, Havarstein LS, et al. A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J Bacteriol. 1992;174:5686-5692.
43.Lewus CB, Sun S, Montville TJ. Production of an amylase-sensitive 1bacteriocin by an typical Leuconostoc paramesenteroides strain. Appl. Environ Microbiol. 1992;58:143-149.
44.Upreti GC, Hinsdill RD. Production and mode of action of lactocin 27: bacteriocin from a homofermentative Lactobacillus. Antimicrob Agents Chemother. 1975 ;7(2):139-45.
45.Bhunia AK, Johnson MC, Ray R, et al. Mode of action of pidiocin AcH from pidiococcus acidilactici H on sensitive bacterial strains. J Appl Bacterial .1991;70:25-33.
46.Gonzalez CF, Kunka BS. Plasmid-Associated Bacteriocin Production and Sucrose Fermentation in Pediococcus acidilactici. Appl Environ Microbiol. 1987;53(10):2534-2538.
47.Yang R, Johnson MC, Ray B. Novel method to extract large amounts of bacteriocins from lactic acid bacteria. Appl Environ Microbiol. 1992; 58: 3355-3359.
48.Daba H, Pandian S, Gosselin JF, et al . Detection and activity of a bacteriocin produced by Leuconostoc mesenteroides. Appl Environ Microbiol. 1991;57:3450-3455.
49.Hechard Y, Deijard B, Letellier F, et al. Characterization purification of mesentericin Y 105, an anti-Listeria bacteriocin form Leuconostoc mesenteroides. J Gen Microbiol. 1992;138: 2725-2731.
50.Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet.1983;1: 1273-1275.
51.陳增興。幽門螺旋桿菌 (Helicobacter pylori)。臨床醫學。1996;38: 83-90。
52.Velayudhan J, Jones MA, Barrow PA, et al. L-serine catabolism via an oxygen-labile L-serine dehydratase is essential for colonization of the avian gut by Campylobacter jejuni. Infection and Immunity. 2004 Jan ;72(1):260-268.
53.Mukai T, Asasaka T, Sato E, et al.Inhibition of binding of Helicobacter pylori to glycolipid receptors by probiotics Lactobactcillus reuteri. Immune Med Microbiol .2002;32:105-110.
54.Felley CP, Corthèsy-Theulaz I, Rivero JLB, et al.Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in human. Eur J Gastroenterol Hepatol. 2001 Jan;13(1):25-29.
55.Goodwin CS. Duodenal ulcer, Campylobacter pylori, and the “leaking roof ” concept. Lancet 1988; 2: 1467-1469.
56.吳明賢、王錦堂。幽門螺旋桿菌之微生物學與基礎研究。內科學誌。1995;6: 4-7。
57.Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents. 2003 Oct;22(4):360-366.
58.McGee DJ, Langford ML, Watson EL, Carter JE, Chen YT, Ottemann KM. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infection and Immunity. 2005 Mar;73(3):1820-1827.
59.王文明。幽門螺旋桿菌之消除與消化性潰瘍之治療。內科學誌。1995;6: 21-29。
60.Coconnier MH, Lievin V, Hemery E, et al. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol. 1998 Nov;64(11):4573-4580.
61.Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion. 1999;60(3):203-9.
62.Nakamura H, Yoshiyama H, Okita T, et al. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Immun 1998;66:4832-4837.
63.Tsai CC, Huang LF, Lin CC, et al. Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39. Int J Food Microbiol. 2004;96(1):1-12.
64.Shima M, Matsuo T, Adachi S. Effects of inner-phase components of water-in-oil-in-water emulsion on low-pH tolerance of Lactobacillus acidophilus incorporated into inner-water phase. J Biosci Bioeng. 2007 Mar;103(3):278-281.
65.Tanner MA, Everett CL, Youvan DC. Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J Clin Microbiol. 2000 Apr;38(4):1628-1631.
66.張書嘉。植生型乳酸菌降膽固醇能力及其相關機制之探討。嘉南藥理科技大學生物科技系碩士論文。2010。
67.Lin WH, Lin CK, Sheu SJ, et al. Antagonistic activity of spent culture supernatants of lactic acid bacteria against Helicobacter pylori growth and infection in human gastric epithelial AGS cells. J Food Sci. 2009 Aug;74(6):M225-230.
68.Messens W, De VL. Inhibitory substances produced by Lactobacilli isolated from sourdoughs--a review.Int J Food Microbiol. 2002 Jan;72(1-2):31-43. Review.
69.Lin CM, Moon SS, Doyle MP, et al. Inactivation of Escherichia coli O157:H7, Salmonella enterica serotype enteritidis, and Listeria monocytogenes on lettuce by hydrogen peroxide and lactic acid and by hydrogen peroxide with mild heat. J Food Prot. 2002 Aug;65(8):1215-1220.
70.Beatriz RB, Yolanda S, Laura N, et al. Coculture-inducible bacteriocin activity of Lactobacillus plantarum strain J23 isolated from grape must. Food Microbiology. 2007;24:482-491.
71.龍湘美。乳酸菌細菌素抗菌作用及其在食品上應用之回顧。國立臺灣海洋大學碩士論文。2003。
連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top